UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Category: Long COVID

Study identifies four major subtypes of long COVID

(Cornell) The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms, according to a study led by researchers at Weill Cornell Medicine. The study, published Dec. 1 in Nature Medicine, was the largest of its kind to examine long COVID. The researchers, who represent clinicians and informaticists, used a machine-learning […]

Jan 3, 2023

Severe COVID-19 increases the risk of schizophrenia

(Psychiatry Research) The coronavirus SARS-CoV-2 invades the central nervous system, impacting the mental health of COVID-19 patients. We performed a two-sample Mendelian randomization analysis to assess the potential causal effects of COVID-19 on schizophrenia. Our analysis indicated that genetic liability to hospitalized COVID-19 was associated with an increased risk for schizophrenia (OR: 1.11, 95% CI: […]

Jan 3, 2023

The Relationship Between Chronic Viral Infection and Long COVID

(NIH) In a small study supported by the National Institute of Allergy and Infectious Diseases (NIAID), researchers found that chronic viral infections may influence the likelihood of someone developing Long COVID. They also found that different chronic infections were associated with the development of different Long COVID symptoms. Some viruses cause underlying chronic infections. These viruses […]

Dec 29, 2022

The epidemiology of long COVID in US adults

(Clinical Infectious Diseases) We estimated the prevalence of long COVID and impact on daily living among a representative sample of adults in the United States (US). We conducted a population-representative survey, June 30-July 2, 2022, of a random sample of 3,042 United States adults aged 18 years or older and weighted to the 2020 US […]

Dec 27, 2022

5 big questions we still need to answer about long covid (Opinion)

(Washington Post) We are nearly three years into the covid-19 pandemic, and the debate about the need for health measures such as vaccine and mask mandates is as hot as ever. One big reason for that: long covid. What even is “long covid”? Broadly speaking, the condition refers to any symptoms persisting weeks to months after […]

Dec 27, 2022

Long COVID: Could mono virus or fat cells be playing roles?

(AP) A British historian, an Italian archaeologist and an American preschool teacher have never met in person, but they share a prominent pandemic bond. Plagued by eerily similar symptoms, the three women are credited with describing, naming and helping bring long COVID into the public’s consciousness in early 2020.

Dec 27, 2022

Are Subphenotypes for Long COVID Beneficial?

(MedPageToday) A recent study opens in a new tab or window published in Nature Medicine, “Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes” by Hao Zhang, PhD, et al. used a data-driven framework to stratify patients suffering with post-acute SARS-CoV-2 (PASC), also referred to as long COVID, into different subcategories of sequelae. The bulk of the patients in the […]

Dec 20, 2022

Scientists’ understanding of long covid is improving

(Economist) PODCAST Our podcast on science and technology. This week, we examine the latest research into what may be causing long covid, and ask whether the hunt for answers could shed light on other chronic conditions. SOON AFTER the pandemic began, another health crisis started to emerge. Long covid now affects millions of people around the world. […]

Dec 13, 2022

New VA study finds Paxlovid may cut the risk of long COVID

(NPR) It’s well-documented that Paxlovid — a 5-day course of antiviral pills from Pfizer — can reduce the risk of hospitalization in COVID-19 patients who are more likely to develop severe illness. Now, researchers from the Veterans Health Administration find that taking the medication may also reduce the risks of later developing long COVID, according […]

Nov 8, 2022

Pfizer’s Paxlovid Antiviral Lowered Long-Covid Risk in Study

(Bloomberg) Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some symptoms of disabling long Covid, a study found.Taking the oral medication within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of lingering […]

Nov 7, 2022